Greenwich LifeSciences, Inc. (GLSI) financial statements and ratios from SEC XBRL: revenue $89700.00 (TTM), net margin -21581.1%, revenue growth -59.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $89700.00 |
| Net Margin | -21581.1% |
| Revenue Growth (YoY) | -59.8% |
| EPS Growth (YoY) | 18.2% |
| Price / Book | 46.36 |
| Price / Sales | 1795.68 |
| Altman Z-Score | -4.88 (distress) |
| Sector P/E (Healthcare) | 21.7 |
GLSI overview · GLSI earnings · GLSI KPIs · GLSI investor relations · GLSI ownership · GLSI peers · GLSI filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.